# US 2010/0137203 A1 · Method for preparing a cell-derived extracellular matrix membrane

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0137203 A1
- Document ID: US20100137203A1
- Status: Published application
- Kind: A1
- Application number: 12/442,499
- Filed: 2007-04-25
- Published: 2010-06-03
- Earliest claimed: 2006-09-21
- Assignees: Regenprime Co., Ltd.
- Inventors: Byoung-Hyun Min; So Ra Park; Byung Hyune Choi
- Web page: https://patentgrep.com/patent/US20100137203A1

## CPC

- A61L 27/3633: {Extracellular matrix [ECM]}
- A61L 27/3683: {subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment}
- A61L 27/3817: {Cartilage-forming cells, e.g. pre-chondrocytes}
- A61L 27/60: Materials for use in artificial skin
- A61P 19/04: for non-specific disorders of the connective tissue
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C12N 5/0655: {Chondrocytes; Cartilage}
- C12N 2533/90: Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to a method for preparing a cell-derived extracellular matrix membrane, more particularly, to a method for preparing a chondrocyte-derived ECM membrane, the method comprising the steps of forming a suitable thickness of ECM membrane by culturing chondrocytes derived from animal cartilage at a high concentration in vitro, and drying it after decellularization process. The cell-derived ECM membrane scaffold according to the present invention is composed of extracellular matrix secreted by chondrocytes so that the membrane has excellent biocompatibility as well as an immune-previlage effect specific to cartilage. Since the membrane also has a suitable compressive strength, it can be used to replace periosteum for cartilage regeneration or artificial collagen membrane and used as dura mater transplant material, a natural ECM membrane for treating skin loss, materials for cell transplantation and a growth factor delivery vehicle.

## Claims

### Claim 1

A method for preparing a chondrocyte-derived ECM membrane, the method comprising the steps of:
(a) isolating chondrocytes from animal-derived cartilage and then culturing them;
(b) obtaining a chondrocyte/ECM membrane from the cultured chondrocytes; and
(c) obtaining an ECM membrane by removing cells from the chondrocyte/ECM membrane and drying the resultant membrane.

### Claim 2 (depends on 1)

The method for preparing a chondrocyte-derived ECM membrane according to claim 1, which additionally comprises a step (d) obtaining a thick ECM membrane with a high compressive strength by reseeding chondrocytes onto the obtained ECM membrane to re-culture.

### Claim 3 (depends on 1)

The method for preparing a chondrocyte-derived ECM membrane according to claim 1, wherein the animal is a pig.

### Claim 4 (depends on 1)

The method for preparing a chondrocyte-derived ECM membrane according to claim 1, wherein the animal is a human.

### Claim 5 (depends on 1, 2)

The method for preparing a chondrocyte-derived ECM membrane according to claims 1 or 2, wherein bioactive factors are additionally added to the culture step.

### Claim 6 (depends on 5)

The method for preparing a chondrocyte-derived ECM membrane according to claim 5, wherein the bioactive factors are more than one selected from the group consisting of insulin-like growth factor (IGF), basic fibroblast growth factor (bFGF), acidic fibroblast growth factor (aFGF), transforming growth factor-alpha (TGF-α), transforming growth factor-beta (TGF-β), bone morphogenetic protein (BMP), platelet-derived growth factor (PDGF), keratinocyte growth factor (KGF), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), Erythropoietin (EPO), granulocyte macrophage colony stimulating factor (GM-CSF), granulocyte colony stimulating factor (G-CSF), nerve growth factor (NGF), heparin binding epidermal growth factor (heparin binding EGF), interferons, tissue activating peptides, interleukin-1 (IL-1), interleukin-2 (IL-2) interleukin-6 (IL-6) and interleukin-8 (IL-8).

### Claim 7 (depends on 1, 2)

The method for preparing a chondrocyte-derived ECM membrane according to claims 1 or 2, wherein the culture broth is treated with ultrasonic waves or physical pressure is applied thereto in the culture step.

### Claim 8 (depends on 1)

The method for preparing a chondrocyte-derived ECM membrane according to claim 1, wherein the drying in step (c) is performed by repeating the procedure of freezing and thawing the chondrocyte/ECM membrane construct at −15˜−25° C., 3˜5 times to naturally dry or freeze-dry.

### Claim 9 (depends on 1, 2)

The method for preparing a chondrocyte-derived ECM membrane according to claims 1 or 2, wherein the step of culturing chondrocytes is performed by culturing them with more than one selected from the group consisting of myoblasts, myocytes, cardiomyocytes, neurons, fibroblasts, fibrocytes, osteoblasts and stem cells.

### Claim 10 (depends on 1, 2)

An ECM membrane prepared by the method of claims 1 or 2.

### Claim 11 (depends on 10)

A method for preparing a decellularized ECM membrane, which comprises removing cells from the ECM membrane of claim 10.

### Claim 12 (depends on 11)

The method for preparing a decellularized ECM membrane according to claim 11, wherein the decellularization is performed by treating the ECM membrane with more than one selected from the group consisting of ionic detergents, nonionic detergents, denaturants, hypotonic solution, DNase, RNase and ultrasonic waves.

### Claim 13 (depends on 11)

A decellularized ECM membrane prepared by the method of claim 11.

### Claim 14

A method for preparing a decellularized ECM membrane, the method comprising the steps of:
(a) producing a chondrocyte/ECM membrane by isolating chondrocytes from animal-derived cartilage to culture;
(b) obtaining a decellularized ECM membrane construct by removing chondrocytes from the produced chondrocyte/ECM membrane; and
(c) obtaining a decellularized ECM membrane by removing cells from the decellularized ECM membrane and drying the resultant membrane.

### Claim 15 (depends on 14)

The method for preparing a decellularized ECM membrane according to claim 14, wherein the chondrocyte removal of the step (b) is performed by treating the chondrocyte/ECM membrane with more than one selected from the group consisting of ionic detergents, nonionic detergents, denaturants, hypotonic solution, DNase, RNase and ultrasonic waves.

### Claim 16 (depends on 14)

A decellularized ECM membrane prepared by the method of claim 14.

### Claim 17 (depends on 10, 13, 16)

A method for preparing an intensive ECM membrane, which comprises increasing thickness of the membrane by multi-layering at least one selected from the group consisting of the ECM membrane of claim 10, the decellularized ECM membrane of claims 13 and 16.

### Claim 18 (depends on 10, 13, 16)

A method for preparing various shapes of the ECM membranes, which comprises processing at least one selected from the group consisting of the ECM membrane of claim 10, the decellularized ECM membrane of claims 13 and 16.

### Claim 19 (depends on 10, 13, 16)

A method for preparing a cell-attached ECM membrane, the method comprising the steps of (a) drying at least one selected from the group consisting of the ECM membrane of claim 10, the decellularized ECM membrane of claims 13 and 16, in a cell culture dish, (b) seeding the cells onto the surface of said ECM membrane or said decellularized ECM membrane.

### Claim 20 (depends on 19)

The method according to claim 19, wherein the cells are selected from the group consisting of chondrocytes, skin cells, nerve cells, muscle cells, pancreatic cells, liver cells and stem cells.

### Claim 21 (depends on 19)

A cellular therapeutic agent containing a cell-seeded ECM membrane prepared by the method of claim 19.

### Claim 22 (depends on 19)

The cellular therapeutic agent according to claim 19, wherein it is for treating cerebral dura mater or regenerating thereof, regenerating skin and cartilage, stanching the bleeding in internal organs, and regenerating tissues of internal organs.

### Claim 23 (depends on 10, 13, 16)

A method for preparing a growth factor-attached ECM membrane, which comprises attaching growth factors to at least one selected from the group consisting of the ECM membrane of claim 10, the decellularized ECM membrane of claims 13 and 16.

### Claim 24 (depends on 23)

A method for preparing an intensive ECM membrane for the controlled release of growth factors, which comprises multi-layering the growth factor-attached ECM membrane prepared by the method of claim 23.

### Claim 25 (depends on 23)

A drug delivery carrier for the controlled release of growth factors, which contains the growth factor-attached ECM membrane prepared by the method of claim 23.

### Claim 26 (depends on 24)

A drug delivery carrier for the controlled release of growth factors, which contains the intensive ECM membrane for the controlled release of growth factors of claim 24.
